No Data
No Data
Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference
Ceribell Announces FedRAMP High Authorization, Expanding Approval For Its AI-Powered Point-Of-Care EEG Across Federal Healthcare Systems
Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025
TD Cowen Maintains Ceribell(CBLL.US) With Buy Rating, Maintains Target Price $36
Ceribell, Inc.: Promising Growth Trajectory and Strong Market Potential Reinforce Buy Rating
CeriBell Says FDA Clears Electrographic Seizure Detection Algorithm